Efficacy and Safety of Cholinesterase Inhibitors in Alzheimer’s Disease: A Meta-analysis
Lane C, Conroy M. Efficacy and Safety of Cholinesterase Inhibitors in Alzheimer’s Disease: A Meta-analysis. 2022, 303-306. DOI: 10.1007/978-3-030-94960-0_53.Peer-Reviewed Original ResearchAlzheimer's diseaseParallel-group trialSafety dataCholinesterase inhibitorsMeta-AnalysisDiseaseAcetylcholinesterase inhibitorsEfficacyInhibitorsTrials